Photocure ASA Logo

Photocure ASA

PHO | OL

Overview

Corporate Details

ISIN(s):
NO0010000045
LEI:
5967007LIEEXZXG8OW35
Country:
Norway
Address:
HOFFSVEIEN 4, 0275 OSLO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Photocure ASA is a specialty pharmaceutical company dedicated to improving the lives of bladder cancer patients. The company develops and commercializes innovative solutions based on its proprietary photodynamic technology platform. This technology is applied in both the diagnosis and treatment of bladder cancer, combining a drug that selectively targets diseased cells with light exposure. This process causes cancer cells to glow bright pink, enabling significantly improved detection during medical procedures. As a commercial-stage company, Photocure is focused on advancing bladder cancer management and delivering better health outcomes for the global urologic oncology community.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Photocure ASA. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 14:39
Regulatory News Service
Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review - A…
English 161.4 KB
2025-08-04 14:39
Regulatory News Service
Asieris: Cevira (APL-1702) NDA Advances to Second Round of Technical Review
English 4.1 KB
2025-07-22 08:00
Report Publication Announcement
Photocure ASA: Invitation to presentation of second quarter and first half year…
English 117.4 KB
2025-07-22 08:00
Report Publication Announcement
Photocure ASA: Invitation to presentation of second quarter and first half year…
English 2.5 KB
2025-06-23 14:55
Director's Dealing
Photocure ASA - Share option grant - Attachment: PHO_OSE_Primary_insider_notifi…
English 161.3 KB
2025-06-23 14:55
Remuneration Information
Photocure ASA - Share option grant - Attachment: Release.pdf
English 138.0 KB
2025-06-23 14:55
Remuneration Information
Photocure ASA - Share option grant
English 3.5 KB
2025-05-08 05:00
Investor Presentation
Photocure ASA: Results for the first quarter of 2025
English 1.2 MB
2025-05-08 05:00
Quarterly Report
Photocure ASA: Results for the first quarter of 2025
English 742.5 KB
2025-05-08 05:00
Earnings Release
Photocure ASA: Results for the first quarter of 2025
English 151.0 KB
2025-05-08 05:00
Earnings Release
Photocure ASA: Results for the first quarter of 2025
English 5.7 KB
2025-05-05 16:12
Post-Annual General Meeting Information
Photocure ASA: Annual general meeting held
English 439.1 KB
2025-05-05 16:12
Post-Annual General Meeting Information
Photocure ASA: Annual general meeting held
English 107.1 KB
2025-05-05 16:12
Post-Annual General Meeting Information
Photocure ASA: Annual general meeting held
English 1.2 KB
2025-04-30 18:57
Report Publication Announcement
Photocure ASA: Invitation to presentation of first quarter 2025 financial resul…
English 117.7 KB

Automate Your Workflow. Get a real-time feed of all Photocure ASA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Photocure ASA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK